Kevin T. Chapman

Statistics

Publications

Citations

11.8K

H-Index

Active since

1980

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Kevin T. Chapman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1980–2017

Publications

A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

Nancy A. Thornberry, Herbert G. Bull, Jimmy Calaycay et al. · Nature · 1992 · 2.6K citations

Life Sciences, Immunology, Molecular Biology +12

A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B

Nancy A. Thornberry, Thomas A. Rano, Erin P. Peterson et al. · Journal of Biological Chemistry · 1997 · 2.1K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Directed reduction of .beta.-hydroxy ketones employing tetramethylammonium triacetoxyborohydride

David A. Evans, Kevin T. Chapman, Erick M. Carreira · Journal of the American Chemical Society · 1988 · 946 citations

Natural Sciences, Biochemistry, Chemistry +6

The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)

Margarita García‐Calvo, JeanMarie Lisnock, Herbert G. Bull et al. · Proceedings of the National Academy of Sciences · 2005 · 768 citations

Life Sciences, Molecular Biology, Pharmacology +14

Asymmetric Diels-Alder cycloaddition reactions with chiral .alpha.,.beta.-unsaturated N-acyloxazolidinones

David A. Evans, Kevin T. Chapman, John J. Bisaha · Journal of the American Chemical Society · 1988 · 635 citations

Natural Sciences, Chemistry, Organic Chemistry +6

1–5 of 88